NEW YORK, NY -- (Marketwire) -- 11/28/12 -- Facebook Inc. (NASDAQ: FB) continues to see growth in Monthly active users (MAUs), recently surpassing 1.01 billion, an increase of 26% year-over-year. We see opportunity in the adoption of mobile, with Facebook's Mobile MAUs increasing at a rate of 61% year-over-year. This is in large part to Facebook's strategy of tight integration with iOS and Android, opening the gateway for mobile ad revenue which is expected to... (Continue Reading).
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced successful Phase III trial results for Pimavanserin. There is currently no FDA-approved therapy to treat PDP in the United States. 60 percent of patients with Parkinson's disease (1 Million Americans, 10 Million worldwide) develop PDP and with average medication costs at $2,500 per year (for Parkinson's patients), we estimate sales upside for Pimavanserin to be between... (Continue Reading).
Intel Corporation (NASDAQ: INTC) is the foremost processor manufacturer, delivering consistent quality and performance -- an important element its competitors fail to match. PC and Notebook Manufacturers looking to produce high-quality products, particularity HP (19% of Intel's income) and Dell (15%), are likely to remain big buyers of Intel's processors. Although there remains threat from ARM architecture and macroeconomic influences (accounting for Intel's recent downward guidance adjustment), Intel's current share price is... (Continue Reading).
Micron Technology, Inc. (NASDAQ: MU) remains one of the largest producers of DRAM and with the upcoming combination of Micron and Elpida, it will have the strongest product portfolio in the industry. We believe this is a net positive, as the Elpida buyout positions Micron as a direct supplier of DRAM for Apple's iPhone and iPad product lines. Mobile devices typically have higher margins than PC DRAM and demand for mobile is growing at a much faster rate, providing a larger offset to Moore's law price declines. Overall, this shift in strategy should... (Continue Reading).